The Age of AI in the Life Sciences Benefits and Biosecurity Considerations
Final Book Now Available Artificial intelligence (AI) applications in the life sciences have the potential to enable advances in biological discovery and design at a faster pace and efficiency than…
Read the full articleYou might also wanna read
How AI and Emerging Biotechnologies Are Reshaping Global Biological Security Risks
Recent outbreaks of disease such as those associated with the Hantavirus or the Ebola virus serve as reminders that biological threats remai
AI leaders warn frontier models and synthetic DNA could lower bioweapons development barriers
Scientists and industry leaders push for mandatory DNA synthesis screening
AI leaders unite in call for US regulations to prevent AI-aided bioweapon development
AI industry rivals rarely agree, but they’re all concerned their technology could be used to develop biological weapons.

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals rarely agree, but they’re all concerned their technology could be used to develop biological weapons.

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals rarely agree, but they’re all concerned their technology could be used to develop biological weapons.
AI's Impact on Cybersecurity: Expert Consultation on Risks, Opportunities, and Policy Options
Artificial intelligence is reshaping cybersecurity at a pace that outstrips the mechanisms society has historically relied on to secure digi
The future of computational biology for macromolecules in the age of AI: challenges and opportunities
We have seen more progress in computational biology for macromolecules in the last five years than we experienced in the five preceding deca
The future of computational biology for macromolecules in the age of AI: challenges and opportunities
We have seen more progress in computational biology for macromolecules in the last five years than we experienced in the five preceding deca

Comments
Sign in to join the conversation.
No comments yet. Be the first.